Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path to FDA EUA, and Commercialization


You May Also Like

Humanigen Announces Positive Topline Study Results

Study Demonstrates that GM-CSF Blockade in Combination with Chimeric Antigen Receptor T Cell Therapy ...

Tyme Adds Distinguished Drug Developer, Briggs W. Morrison, M.D. to Advisory Board

NEW YORK, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (Nasdaq:TYME), a biotechnology ...